Complexity of molecular alterations impacts pancreatic cancer prognosis

作     者：Ivonne Regel Bo Kong Philipp Bruns Christoph W Michalski Jrg Kleeff 

作者机构：Department of SurgeryTechnische Universitt München 

出 版 物：《World Journal of Gastrointestinal Oncology》 (世界胃肠肿瘤学杂志（英文版）（电子版）)

年 卷 期：2013年第5卷第1期

页      面：1-3页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Pancreatic cancer Diagnostic markers Biomarkers Targeted therapy Prognosis Pathways 

摘      要：Individualized cancer treatment(*** therapy) based on molecular alterations has emerged as an important strategy to improve the current standardof-care chemotherapy.A large number of studies have demonstrated the importance of biomarkers not only in predicting prognosis but more importantly in predicting the response towards *** example,amplification or mutation status of the two biomarkers HER2(human epidermal growth factor 2) and BRCA(breast cancer) can be used to decide on a specific targeted therapy in breast ***,no biomarkers with a similar clinical impact have been identified in pancreatic ductal *** many genome-wide and proteome-based high-throughput studies have identified candidate genes or proteins as promising biomarkers,none of them were eventually transferred into the clinical ***,the most reliable markers for predicting prognosis are still the tumor stage and grade and biomarkers for therapy response remain *** reason lies in the lack of systemic approaches to analyze the complexity of dominating cancer pathways and the impact of such signal complexity on prognosis and therapy response.